87 related articles for article (PubMed ID: 20103605)
1. Ligand-specific antibodies to insulin-like growth factors suppress intestinal polyp formation in Apc+/- mice.
Matsunaka T; Miyamoto S; Shitara K; Ochiai A; Chiba T
Mol Cancer Ther; 2010 Feb; 9(2):419-28. PubMed ID: 20103605
[TBL] [Abstract][Full Text] [Related]
2. Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers.
Miyamoto S; Nakamura M; Shitara K; Nakamura K; Ohki Y; Ishii G; Goya M; Kodama K; Sangai T; Maeda H; Shi-Chuang Z; Chiba T; Ochiai A
Clin Cancer Res; 2005 May; 11(9):3494-502. PubMed ID: 15867252
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouse.
Araki K; Sangai T; Miyamoto S; Maeda H; Zhang SC; Nakamura M; Ishii G; Hasebe T; Kusaka H; Akiyama T; Tokuda Y; Nagai K; Minami H; Ochiai A
Int J Cancer; 2006 May; 118(10):2602-8. PubMed ID: 16353147
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412
[TBL] [Abstract][Full Text] [Related]
5. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
Ji QS; Mulvihill MJ; Rosenfeld-Franklin M; Cooke A; Feng L; Mak G; O'Connor M; Yao Y; Pirritt C; Buck E; Eyzaguirre A; Arnold LD; Gibson NW; Pachter JA
Mol Cancer Ther; 2007 Aug; 6(8):2158-67. PubMed ID: 17671083
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of insulin-like growth factor (IGF)-binding proteins-1 and -3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts.
Okajima T; Iwashita M; Takeda Y; Sakamoto S; Tanabe T; Yasuda T; Rosenfeld RG
J Endocrinol; 1993 Mar; 136(3):457-70. PubMed ID: 7682592
[TBL] [Abstract][Full Text] [Related]
7. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development.
Mandir N; Englyst H; Goodlad RA
Br J Nutr; 2008 Oct; 100(4):711-21. PubMed ID: 18279550
[TBL] [Abstract][Full Text] [Related]
8. Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout mice.
Hioki K; Shivapurkar N; Oshima H; Alabaster O; Oshima M; Taketo MM
Carcinogenesis; 1997 Oct; 18(10):1863-5. PubMed ID: 9363991
[TBL] [Abstract][Full Text] [Related]
9. Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model.
Yin SC; Guo W; Tao ZZ
Biochem Biophys Res Commun; 2013 Sep; 439(1):1-5. PubMed ID: 23973483
[TBL] [Abstract][Full Text] [Related]
10. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling.
Chen HZ; Liu QF; Li L; Wang WJ; Yao LM; Yang M; Liu B; Chen W; Zhan YY; Zhang MQ; Cai JC; Zheng ZH; Lin SC; Li BA; Wu Q
Gut; 2012 May; 61(5):714-24. PubMed ID: 21873734
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin.
Friedbichler K; Hofmann MH; Kroez M; Ostermann E; Lamche HR; Koessl C; Borges E; Pollak MN; Adolf G; Adam PJ
Mol Cancer Ther; 2014 Feb; 13(2):399-409. PubMed ID: 24296829
[TBL] [Abstract][Full Text] [Related]
12. The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc
Ono J; Shime H; Takaki H; Takashima K; Funami K; Yoshida S; Takeda Y; Matsumoto M; Kasahara M; Seya T
J Biomed Sci; 2017 Oct; 24(1):79. PubMed ID: 29041928
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation.
Huang CT; Chang MC; Chen YL; Chen TC; Chen CA; Cheng WF
Cancer Lett; 2015 Apr; 359(1):117-26. PubMed ID: 25592043
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
15. Treatment with anti-interleukin-6 receptor antibody ameliorates intestinal polyposis in Apc(Min/+) mice under high-fat diet conditions.
Yaoita T; Sasaki Y; Yokozawa J; Sato T; Kanno N; Sakuta K; Yagi M; Yoshizawa K; Iwano D; Nagino K; Nomura E; Abe Y; Nishise S; Takeda H; Kawata S; Ueno Y
Tohoku J Exp Med; 2015 Feb; 235(2):127-34. PubMed ID: 25746084
[TBL] [Abstract][Full Text] [Related]
16. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA
Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437
[TBL] [Abstract][Full Text] [Related]
18. Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice.
Onuma W; Tomono S; Miyamoto S; Fujii G; Hamoya T; Fujimoto K; Miyoshi N; Fukai F; Wakabayashi K; Mutoh M
Oncotarget; 2016 Feb; 7(8):8640-52. PubMed ID: 26840084
[TBL] [Abstract][Full Text] [Related]
19. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.
Mochida Y; Taguchi K; Taniguchi S; Tsuneyoshi M; Kuwano H; Tsuzuki T; Kuwano M; Wada M
Carcinogenesis; 2003 Jul; 24(7):1219-24. PubMed ID: 12807720
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.
Savari S; Chandrashekar NK; Osman J; Douglas D; Bellamkonda K; Jönsson G; Juhas M; Greicius G; Pettersson S; Sjölander A
Carcinogenesis; 2016 May; 37(5):491-9. PubMed ID: 26979937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
